Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective.

Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer’s disease from a ferroptosis perspective.
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective. Prog Neurobiol. 2019 Oct 08;:101716 Authors: Derry PJ, Hegde ML, Jackson GR, Kayed R, Tour JM, Kent TA, Tsa AL Abstract The complexity of Alzheimer's disease (AD) complicates the search for effective treatments. While the key roles of pathologically modified proteins has occupied ... read more
Source: PubMedPublished on 2019-10-12